LianBio Dividends and Buybacks
Dividend criteria checks 2/6
LianBio is a dividend paying company with a current yield of 2432.65%.
Key information
2,432.7%
Dividend yield
0%
Buyback Yield
Total Shareholder Yield | 0% |
Future Dividend Yield | 0% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
With No Cure In Sight, Drugs Firm LianBio Begins Exit Strategy
Feb 23LianBio (NASDAQ:LIAN) Is In A Good Position To Deliver On Growth Plans
Jul 20We're Hopeful That LianBio (NASDAQ:LIAN) Will Use Its Cash Wisely
Apr 05We Think LianBio (NASDAQ:LIAN) Can Afford To Drive Business Growth
Dec 20Companies Like LianBio (NASDAQ:LIAN) Are In A Position To Invest In Growth
Sep 02Will LianBio (NASDAQ:LIAN) Spend Its Cash Wisely?
May 17LianBio: An Undervalued Play On The $220B/Year Chinese Pharmaceutical Market
Mar 03Here's Why LianBio (NASDAQ:LIAN) Must Use Its Cash Wisely
Feb 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if LIAN.Y's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LIAN.Y's dividend payments have been increasing.
Dividend Yield vs Market
LianBio Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (LIAN.Y) | 2,432.7% |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.4% |
Industry Average (Biotechs) | 2.4% |
Analyst forecast (LIAN.Y) (up to 3 years) | 0% |
Notable Dividend: LIAN.Y's dividend (2432.65%) is higher than the bottom 25% of dividend payers in the US market (1.41%).
High Dividend: LIAN.Y's dividend (2432.65%) is in the top 25% of dividend payers in the US market (4.43%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate LIAN.Y's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LIAN.Y has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/02 20:37 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2023/09/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LianBio is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Geoffrey Meacham | BofA Global Research |
Ziyi Chen | Goldman Sachs |
Michael Yee | Jefferies LLC |